Literature DB >> 12700405

Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid.

Tamotsu Takizawa1, Kunitoshi Mitsumori, Toru Tamura, Masahiro Nasu, Makoto Ueda, Toshio Imai, Masao Hirose.   

Abstract

In order to evaluate the tumorigenic potential of kojic acid (KA), used as a food additive for preventing enzymatic browning of crustaceans and a cosmetic agent for the purpose of skin whitening, heterozygous p53-deficient CBA [p53(+/-)] mice, which are recognized as useful for detecting genotoxic carcinogens, and wild-type littermates [p53(+/+) mice] were fed diet containing 0, 1.5, and 3% KA for 26 weeks. KA induced diffuse hypertrophy and hyperplasia of thyroid follicular epithelial cells with decreased serum thyroxine levels in both p53 (+/-) and p53 (+/+) mice, but caused no thyroid tumors. In the liver, the incidence of altered hepatocellular foci was significantly increased at 1.5 and 3% in p 53(+/-) and 1.5% in p53 (+/+) mice, and that of hepatocellular adenomas was increased at 1.5 and 3% in p 53(+/-) and 3% in p53 (+/+) mice. p53 (+/-) mice thus appeared to be more susceptible in terms of the tumorigenic dose of KA with a greater prevalence of hepatic proliferative lesions. The results of the present study indicate tumorigenic potential of KA in the liver, but not thyroid follicular epithelial cells in CBA mice and a contribution of genotoxicity on hepatocellular tumor development cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700405     DOI: 10.1093/toxsci/kfg094

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

Review 1.  Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders.

Authors:  Hideya Ando; Mary S Matsui; Masamitsu Ichihashi
Journal:  Int J Mol Sci       Date:  2010-06-18       Impact factor: 5.923

2.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

3.  S-(-)-10,11-dihydroxyfarnesoic acid methyl ester inhibits melanin synthesis in murine melanocyte cells.

Authors:  Seung-Hwa Baek; Jun-Won Ahn; Sung-Hee Nam; Cheol-Sik Yoon; Jae-Cheon Shin; Sang-Han Lee
Journal:  Int J Mol Sci       Date:  2014-07-18       Impact factor: 5.923

4.  Inhibitory effects of Taraxacum mongolicum with phreatic water on melanin synthesis.

Authors:  Moon-Hee Jang; Taek-Won Ahn
Journal:  Integr Med Res       Date:  2014-08-30

Review 5.  Fermented broth in tyrosinase- and melanogenesis inhibition.

Authors:  Chin-Feng Chan; Ching-Cheng Huang; Ming-Yuan Lee; Yung-Sheng Lin
Journal:  Molecules       Date:  2014-08-26       Impact factor: 4.411

Review 6.  Timeline of the Development of Skin-Lightening Active Ingredients in Japan.

Authors:  Kazuhisa Maeda
Journal:  Molecules       Date:  2022-07-26       Impact factor: 4.927

7.  Asoprisnil, a Selective Progesterone Receptor Modulator (SPRM), Inhibits Melanosome Export in B16F10 Cells and HEMn-DP Melanocytes.

Authors:  Shilpi Goenka; Sanford R Simon
Journal:  Molecules       Date:  2020-08-06       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.